Caricamento...
Potential Adiponectin Receptor Response Modifier Therapeutics
Many human diseases may benefit from adiponectin replacement therapy, but due to pharmacological disadvantages of the intact protein, druggable options focus on peptidic, and small molecule agonists of the adiponectin receptor. Peptide-based adiponectin replacement drug leads are derived from, or re...
Salvato in:
| Pubblicato in: | Front Endocrinol (Lausanne) |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6700268/ https://ncbi.nlm.nih.gov/pubmed/31456747 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2019.00539 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|